(HealthDay News) — Here are the latest clinical trials, courtesy of CenterWatch:

Prostate Disorders

This is a clinical study to test the safety and efficacy of a study drug in subjects with an enlarged prostate gland.

You may qualify to participate if you are a male between 65 and 80 years old (or between 40 and 80 years old with vasectomy), have symptomatic benign prostatic hyperplasia (BPH), have not had prior surgery of the prostate (except biopsies), and have not had current or past evidence of malignant disease of the prostate.

The research site is in New York City.

More Information

Please see http://www.centerwatch.com/patient/studies/cat125.html

—–

student loan calculator Systemic Lupus Erythematosus

This seo services research study will test an investigational new drug to evaluate whether it is safe and effective for people who have been diagnosed with systemic lupus erythematosus (SLE).

Volunteers who are at least 18 years old, have been diagnosed with SLE, are receiving either an immunosuppressant or antimalarial, and are not a pregnant woman or one who is breast-feeding, may be eligible to participate.

The research site is in Ogden, Utah.

More Information

Please see http://www.centerwatch.com/patient/studies/cat144.html

—–

Lung Cancer

This is a multicenter, open-label, randomized phase 1 study of escalating doses of Tarceva in patients with advanced non-small cell lung cancer (NSCLC) who currently smoke.

If you have a histologically or cytologically confirmed diagnosis of stage IIIB/IV NSCLC, have received 1 or 2 prior chemotherapy regimens for advanced NSCLC and now have progressive disease and have not had any concurrent anticancer cytostatic or cytotoxic chemotherapy, you may be eligible to participate.

Research sites are located throughout the United States and the United Kingdom.

More Information

Please see http://www.centerwatch.com/patient/studies/cat34.html.

—–

Copyright 2006 CenterWatch. All rights reserved.